NCT05520892
- Conditions
- Newly Diagnosed Immune Thrombocytopenia in Children, First Line Treatment
- Locations
-
- Children with newly dignosed ITP Fuzhou, Fujian, China
Clinical trial condition
Newly Diagnosed Immune Thrombocytopenia in Children, First Line Treatment
Explore clinical trials studying Newly Diagnosed Immune Thrombocytopenia in Children, First Line Treatment. Study availability and eligibility vary by location and protocol.
1 public trial
1 recruiting study